+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pain Management Devices Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5021817
  • Report
  • January 2020
  • Region: Global
  • 213 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Medtronic Plc.
  • MORE
The global pain management devices market was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, registering a CAGR of 6.7% from 2019 to 2026. Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are different forms of pain management devices available in the market.

Significant increase in prevalence of chronic pain, rise in geriatric population, surge in awareness among people toward pain management devices, and an increase in demand for pain management devices in developing region are the key factors that fuel the growth of the market. Moreover, availability of innovative pain management devices, surge in R&D activities to develop technologically advanced pain management devices, increase in availability of lower cost portable products, and development of the medical device industry across the globe are other factors that contribute toward the growth of the market. However, hypersensitivity reactions and post-operative infections caused due to the use these devices limit their adoption. Moreover, they are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which hinders the growth of the market.

The pain management devices market is segmented into type, application, and region. By type, the market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Depending on application, it is classified into cancer pain, neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Product Type
  • Neuromodulation & Neurostimulation devices
  • Analgesic Infusion Pumps
  • Ablation Devices
By Application
  • Neuropathic Pain
  • Cancer Pain
  • Facial & Migraine Pain
  • Musculoskeletal Pain
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp
  • DJO Global LLC
  • Johnson & Johnson (Codman And Shurtleff, Inc,)
  • Kimberly Clark Corporation
  • Medtronic Plc
  • Pfizer, Inc.
  • Stryker Corp.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Halyard Health, Inc.
  • Neurotech NA, Inc.
  • Nevro Corp
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Medtronic Plc.
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Porter's Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase In Prevalence of Chronic Disease
3.4.1.2. Rise In In Geriatric Population
3.4.1.3. the increase in the adoption of Pain Management Devices
3.4.2. Restraint
3.4.2.1. Preferable Use of Medications For Pain Management
3.4.3. Opportunities
3.4.3.1. Growth Opportunities In Emerging Markets
3.4.4. Impact Analysis

Chapter 4: Pain Management Devices Market, By Product Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Neuromodulation & Neurostimulation Devices
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Type
4.2.2.1. Spinal Cord Stimulators
4.2.2.1.1. Market Size And Forecast
4.2.2.2. Transcutaneous Electrical Nerve Stimulation (Tens) Devices
4.2.2.2.1. Market Size And Forecast
4.2.3. Market Size And Forecast, By Region
4.2.4. Market Analysis, By Country
4.3. Analgesic Infusion Pumps
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Type
4.3.2.1. External Infusion Pumps
4.3.2.1.1. Market Size And Forecast
4.3.2.2. Intrathecal Infusion Pumps
4.3.2.2.1. Market Size And Forecast
4.3.3. Market Size And Forecast
4.3.4. Market Analysis, By Country
4.4. Ablation Devices
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast
4.4.3. Market Analysis, By Country

Chapter 5: Pain Management Devices Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Neuropathic Pain
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Cancer Pain
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country
5.4. Facial & Migraine Pain
5.4.1. Market Size And Forecast
5.4.2. Market Analysis, By Country
5.5. Musculoskeletal Pain
5.5.1. Market Size And Forecast
5.5.2. Market Analysis, By Country
5.6. Others
5.6.1. Market Size And Forecast
5.6.2. Market Analysis, By Country

Chapter 6: Pain Management Devices Market, By Region
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends, Growth Factors, And Opportunities
6.2.2. Market Size And Forecast, By Country
6.2.2.1. U.S.
6.2.2.1.1. U.S. Pain Management Devices Market, By Product Type
6.2.2.1.2. U.S. Pain Management Devices Market, By Application
6.2.2.2. Canada
6.2.2.2.1. Canada Pain Management Devices Market, By Product Type
6.2.2.2.2. Canada Pain Management Devices Market, By Application
6.2.2.3. Mexico
6.2.2.3.1. Mexico Pain Management Devices Market, By Product Type
6.2.2.3.2. Mexico Pain Management Devices Market, By Application
6.2.3. North America Market Size And Forecast, By Product Type
6.2.4. North America Pain Management Devices Market, By Application
6.3. Europe
6.3.1. Key Market Trends, Growth Factors, And Opportunities
6.3.2. Market Size And Forecast, By Country
6.3.2.1. Germany
6.3.2.1.1. Germany Pain Management Devices Market, By Product Type
6.3.2.1.2. Germany Pain Management Devices Market, By Application
6.3.2.2. France
6.3.2.2.1. France Pain Management Devices Market, By Product Type
6.3.2.2.2. France Pain Management Devices Market, By Application
6.3.2.3. UK
6.3.2.3.1. UK Pain Management Devices Market, By Product Type
6.3.2.3.2. UK Pain Management Devices Market, By Application
6.3.2.4. Italy
6.3.2.4.1. Italy Pain Management Devices Market, By Product Type
6.3.2.4.2. Italy Pain Management Devices Market, By Application
6.3.2.5. Spain
6.3.2.5.1. Spain Pain Management Devices Market, By Product Type
6.3.2.5.2. Spain Pain Management Devices Market, By Application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe Pain Management Devices Market, By Product Type
6.3.2.6.2. Rest of Europe Pain Management Devices Market, By Application
6.3.3. Europe Market Size And Forecast, By Product Type
6.3.4. Europe Pain Management Devices Market, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends, Growth Factors, And Opportunities
6.4.2. Market Size And Forecast, By Country
6.4.2.1. Japan
6.4.2.1.1. Japan Pain Management Devices Market, By Product Type
6.4.2.1.2. Japan Pain Management Devices Market, By Application
6.4.2.2. China
6.4.2.2.1. China Pain Management Devices Market, By Product Type
6.4.2.2.2. China Pain Management Devices Market, By Application
6.4.2.3. Australia
6.4.2.3.1. Australia Pain Management Devices Market, By Product Type
6.4.2.3.2. Australia Pain Management Devices Market, By Application
6.4.2.4. India
6.4.2.4.1. India Pain Management Devices Market, By Product Type
6.4.2.4.2. India Pain Management Devices Market, By Application
6.4.2.5. South Korea
6.4.2.5.1. South Korea Pain Management Devices Market, By Product Type
6.4.2.5.2. South Korea Pain Management Devices Market, By Application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific Pain Management Devices Market, By Product Type
6.4.2.6.2. Rest of Asia-Pacific Pain Management Devices Market, By Application
6.4.3. Asia-Pacific Market Size And Forecast, By Product Type
6.4.4. Asia-Pacific Pain Management Devices Market, By Application
6.5. LAMEA
6.5.1. Key Market Trends, Growth Factors, And Opportunities
6.5.2. Market Size And Forecast, By Country
6.5.2.1. Brazil
6.5.2.1.1. Brazil Pain Management Devices Market, By Product Type
6.5.2.1.2. Brazil Pain Management Devices Market, By Application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia Pain Management Devices Market, By Product Type
6.5.2.2.2. Saudi Arabia Pain Management Devices Market, By Application
6.5.2.3. South Africa
6.5.2.3.1. South Africa Pain Management Devices Market, By Product Type
6.5.2.3.2. South Africa Pain Management Devices Market, By Application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA Pain Management Devices Market, By Product Type
6.5.2.4.2. Rest of LAMEA Pain Management Devices Market, By Application
6.5.3. LAMEA Market Size And Forecast, By Product Type
6.5.4. LAMEA Pain Management Devices Market, By Application

Chapter 7: Company Profiles
7.1. Abbott Laboratories
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.1.6. Key Strategic Moves And Developments
7.2. B Braun Melsungen Ag
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Baxter International Inc.
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Boston Scientific Corporation
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves And Developments
7.5. Djo Global Llc
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Johnson & Johnson (Codman And Shurtleff, Inc.,)
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Kimberly-Clark Corporation (Baylis Medical)
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Medtronic Plc
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.8.6. Key Strategic Moves And Developments
7.9. Pfizer Inc. (Hospira Inc.)
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Stryker Corporation
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Medtronic Plc.
  • MORE
According to the report, titled, 'Pain Management Devices Market by Product Type, and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global pain management devices market size was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, growing at a CAGR of 6.7% from 2019 to 2026.

Pain management is a branch of medical science, which eases the suffering of patients suffering from chronic pain or acute pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation (TENS) devices, intrathecal infusion pumps, external infusion pumps, and others are widely used in management of chronic pain.

The pain management devices market is expected to experience significant growth during the forecast period, owing to rise in prevalence of chronic pain, surge in demand for long-term pain management devices, adverse effects associated with pain therapeutics, and availability of technologically advanced devices coupled with rise in adoption of these devices. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 50 million of American adults suffer from chronic pain. The American Academy of Pain Medicine reports that more than 1.5 billion people worldwide suffer from chronic pain and that approximately 5-7% of the global population suffers from neuropathic pain.

In addition, increase in demand for pain management devices, upsurge in awareness among people towards pain management devices, and an increase in healthcare expenditure across the globe are expected to drive the growth of global pain management devices market.

However, hypersensitivity reactions post-operative infection caused by the use of these devices limit the growth of the market. Moreover, they are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy can, which impedes their adoption globally, thereby restraining the market growth.

On the basis of type, the market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Presently, the neuromodulation & neurostimulation devices segment dominates the global market, and is anticipated to continue this trend during the forecast period. This is attributed to surge in demand neuromodulation & neurostimulation devices, due to their cost efficiency and an increase in number target population.

By application, the market is classified into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. At present, the neuropathic pain segment garners the major share, owing to surge in number of target population, technological advancements in pain management devices, and rise in demand for pain management devices for management of neuropathic pain.

Key Findings of the Study
By product, the neuromodulation & neurostimulation devices segment held more than half share in the global market in 2018.
Depending on application, the neuropathic pain segment held more than one-third share in the global market in 2018.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.6% during the forecast period.
North America accounted for approximately one-half of the global pain management devices market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of pain management devices, higher number of target population, ease of access to innovative products, availability of well-developed healthcare infrastructure, and strong presence of key players. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to improvement in healthcare infrastructure, rise in number advanced medical facilities, surge in awareness regarding pain management devices, and an increase in number of target population.
Note: Product cover images may vary from those shown
4 of 5
  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Johnson & Johnson (Codman And Shurtleff Inc.,)
  • Kimberly Clark Corporation
  • Medtronic Plc.
  • Pfizer Inc.
  • Stryker Corp.
Note: Product cover images may vary from those shown
5 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll